Literature DB >> 18514392

An intraventricular clear cell meningioma revealed by an inflammatory syndrome in a male adult: a case report.

J Cassereau1, C Lavigne, S Michalak-Provost, A Ghali, F Dubas, H D Fournier.   

Abstract

Intraventricular meningiomas are infrequent intracranial tumors. Clinical symptoms are mainly due to an increased intracranial pressure or a direct pressure on the surrounding brain structures. Inflammatory syndrome was described in some patients with chordoid meningiomas. Here we report a case of right intraventricular clear cell meningioma in a 50-year-old man who presented with fever, headache, and inflammatory syndrome. Clinical and biological normalization was rapidly obtained after tumor removal. Immunohistochemical examination showed tumor cells and lymphocytes positivity for the pyrogenic cytokine interleukin-6, with a same intensity. To our knowledge, this is the first case described in the literature concerning an adult man with an intraventricular clear cell meningioma associated with a systemic inflammatory syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514392     DOI: 10.1016/j.clineuro.2008.04.008

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  3 in total

1.  Chordoid meningioma: a clinicopathologic study of 11 cases at a single institution.

Authors:  Jui-Wei Lin; Jih-Tsun Ho; Yu-Jun Lin; You-Ting Wu
Journal:  J Neurooncol       Date:  2010-05-09       Impact factor: 4.130

Review 2.  Natural history of intraventricular meningiomas: systematic review.

Authors:  Benedito Jamilson Araújo Pereira; Antônio Nogueira de Almeida; Wellingson Silva Paiva; Paulo Henrique Pires de Aguiar; Manoel Jacobsen Teixeira; Suely Kazue Nagahashi Marie
Journal:  Neurosurg Rev       Date:  2018-08-15       Impact factor: 3.042

3.  Molecular progression in unusual recurrent non-pediatric intracranial clear cell meningioma.

Authors:  B Domingo-Arrué; R Gil-Benso; J Megías; L Navarro; T San-Miguel; L Muñoz-Hidalgo; C López-Ginés; M Cerdá-Nicolás
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.